Letter to Editor

Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis

Volume: 5 Number: 1 January 4, 2019
The European Research Journal Cover
The European Research Journal
PDF Download
EN

Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis

Abstract

No abstract available.

Keywords

References

  1. [1] George JN. How I treat patients with thrombotic thrombocytopenic purpura:2010. Blood 2010;116:4060-9.
  2. [2] Kremer Hovinga JA, Vesely SK, Terrell DR, Lammle B, George JN. Survival and relapse in patient with thrombotic thrombocytopenic purpura. Blood 2010;115:1500-11.
  3. [3] George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher 2006;21:49-56.
  4. [4] Ling HT, Field JJ, Blinder MA. Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature. Am J Hematol 2009;84:418-21.
  5. [5] McDonald V, Manns K, Mackie IJ, Machin SJ, Scully MA. Rituximab pharmakonetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. J Thromb Haemost 2010;8:1201-8.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Letter to Editor

Authors

Hilmi Erdem Sümbül *
Health and Science University ,Adana Şehir Training and Research Hospital
0000-0002-7192-0280
Türkiye

Onur Taktakoğlu This is me
Cukurova University
0000-0002-9017-7760
Türkiye

Publication Date

January 4, 2019

Submission Date

February 3, 2018

Acceptance Date

June 1, 2018

Published in Issue

Year 2019 Volume: 5 Number: 1

DOI

https://doi.org/10.18621/eurj.389830

IZ

https://izlik.org/JA34MY89ND

Cite

RIS / Bibtex
APA
Sümbül, H. E., & Taktakoğlu, O. (2019). Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis. The European Research Journal, 5(1), 233-235. https://doi.org/10.18621/eurj.389830
AMA
1.Sümbül HE, Taktakoğlu O. Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis. Eur Res J. 2019;5(1):233-235. doi:10.18621/eurj.389830
Chicago
Sümbül, Hilmi Erdem, and Onur Taktakoğlu. 2019. “Experience of Thrombotic Microangiopathy Unresponsive to Therapeutic Apheresis”. The European Research Journal 5 (1): 233-35. https://doi.org/10.18621/eurj.389830.
EndNote
Sümbül HE, Taktakoğlu O (January 1, 2019) Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis. The European Research Journal 5 1 233–235.
IEEE
[1]H. E. Sümbül and O. Taktakoğlu, “Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis”, Eur Res J, vol. 5, no. 1, pp. 233–235, Jan. 2019, doi: 10.18621/eurj.389830.
ISNAD
Sümbül, Hilmi Erdem - Taktakoğlu, Onur. “Experience of Thrombotic Microangiopathy Unresponsive to Therapeutic Apheresis”. The European Research Journal 5/1 (January 1, 2019): 233-235. https://doi.org/10.18621/eurj.389830.
JAMA
1.Sümbül HE, Taktakoğlu O. Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis. Eur Res J. 2019;5:233–235.
MLA
Sümbül, Hilmi Erdem, and Onur Taktakoğlu. “Experience of Thrombotic Microangiopathy Unresponsive to Therapeutic Apheresis”. The European Research Journal, vol. 5, no. 1, Jan. 2019, pp. 233-5, doi:10.18621/eurj.389830.
Vancouver
1.Hilmi Erdem Sümbül, Onur Taktakoğlu. Experience of thrombotic microangiopathy unresponsive to therapeutic apheresis. Eur Res J. 2019 Jan. 1;5(1):233-5. doi:10.18621/eurj.389830